UK BROKER RATINGS SUMMARY: UBS High On Glaxo, Deutsche Down On Aviva
UK BROKER RATINGS SUMMARY: UBS High On Glaxo, Deutsche Down On Aviva
Read moreUK BROKER RATINGS SUMMARY: UBS High On Glaxo, Deutsche Down On Aviva
Read more* Spanish bourse BME hits 4-year high* Volkswagen cuts sales and profit forecast* Defensive shares gain amid trade uncertainty* FTSE 100 outperforms (Updates to close, changes quotes, adds news items)By Medha Singh and Agamoni GhoshNov 18 (Reuters) ...
Read more(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.
Read more* 2nd bioreactor to remove bottleneck in 2024* Plans to produce "high teens" of mln doses in 2019* New facility would add tens of mln of doses per yr* China market for now a distant opportunity (Adds role of vaccines for GSK, details on China launch...
Read moreWAVRE, Belgium, Nov 15 (Reuters) - GlaxoSmithKline said further growth from its shingles vaccine, which has boosted earnings, would be reined in by limited capacity until 2024, but a new bioreactor facility would then be ready to bring a "step ch...
Read moreUK BROKER RATINGS SUMMARY: Jefferies And JPMorgan Both Cut Tullow Oil
Read more* FTSE 100 down 0.8%, FTSE 250 down 0.3%* Burberry jumps after Q2 results* 3i drops after H1 report* FirstGroup marks worst day in more than a year (Adds news items, updates to close)By Shashwat Awasthi and Muvija MNov 14 (Reuters) - London's FTSE 1...
Read more* FTSE 100 down 0.1%, FTSE 250 flat* Burberry jumps after Q2 results* 3i drops after H1 report* FirstGroup tracking worst day in more than a year (Adds news items, analyst comment, updates share prices)By Shashwat AwasthiNov 14 (Reuters) - London's ...
Read moreBERLIN, Nov 14 (Reuters) - Germany's Merck KGaA on Thursday raised its full-year 2019 forecast for sales and adjusted earnings after completing the takeover of electronic materials maker Versum Materials in October.Merck said its 2019 net sales wo...
Read more(Sharecast News) - Associated British Foods: Goldman Sachs upgrades to buy with a target price of 2,750p.
Read moreDIRECTOR DEALINGS: GlaxoSmithKline Divisional Presidents Sell Shares
Read more(Sharecast News) - Analysts at Liberum hiked their target price for shares of GlaxoSmithKline after switching valuation methods given the company's medium-term plans to split its Consumer Health business from its Pharmaceuticals arm.
Read moreUK BROKER RATINGS SUMMARY: Peel Hunt Initiates Whitbread With Buy
Read moreUK BROKER RATINGS SUMMARY: UBS Cuts Euromoney And Crest Nicholson
Read more